Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Topotecan and Avastin in Advanced NSCLC
NCT00365547Phase 2Completed
- Sponsor
- Masonic Cancer Center
- Start
- Sep 2006
- Primary completion
- Sep 2011
- Modality
- Monoclonal Antibodies, Targeted Liposomes, Stealth (PEGylated) Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of topotecan liposome, bevacizumab in non-small cell lung cancer (NSCLC), sponsored by Masonic Cancer Center. Started Sep 2006; status: completed.
02
Drugs
topotecan liposomebevacizumab
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00365547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00365547.